2021
March
Establishment of the company's founding team
Establish in-depth cooperation with Suzhou University and Suzhou Institute of nanotechnology, Chinese Academy of Sciences
May
Suzhou Huiyi biology was established and settled in 2.5 Industrial Park
Obtain Angel round investment from Sequoia Capital, Jinpu investment, huiding investment and other institutions
Won the leading (incubation) project of science and technology in Suzhou Industrial Park
August
Reach deep cooperation with leading vaccine Enterprises
Promote the development of infectious disease vaccine and tumor treatment product pipeline
November
1600 square meters of site construction, 800 square meters of GMP pilot test completed
Set up Suzhou University Huihui RNA drug Collaborative Innovation Center
Establish Suzhou University Graduate workstation
2022
April
Rated as a national science and technology-based small and medium-sized enterprise
May
Rated as A-level enterprise of quality credit in Jiangsu Province
June
Rated as a private technology enterprise in Jiangsu Province
September
Selected as "the first batch of Suzhou innovation and entrepreneurship leading talent enterprises in 2022"
